0.66 USD
▼+0.02-4.84%
盘后 0.69 -0.82%
2026-08-03
市值
$54.56M
市盈率
—
EPS
-1.56
股息率
—
52 周区间
0.56 – 2.98
成交量
3.99M
Beta
1.51
目标价
2.77
52W 低 0.5652W 高 2.98
价格走势
公司简介
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses SynCon, to help engineer precisely designed plasmid DNA plasmids, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company’s lead product candidate is INO-3107 for HPV-related recurrent respiratory papillomatosis and i...